The PE Ratio as of December 2024 (TTM) for Vincerx Pharma, Inc. (VINC) is -0.22

According to Vincerx Pharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.22. This represents a change of -90.07% compared to the average of -2.22 of the last 4 quarters.

Vincerx Pharma, Inc. (VINC) Historical PE Ratio (quarterly & annually)

How has VINC PE Ratio performed in the past?

The mean historical PE Ratio of Vincerx Pharma, Inc. over the last ten years is -223.82. The current -0.22 PE Ratio has changed -90.17% with respect to the historical average. Over the past ten years (40 quarters), VINC's PE Ratio was at its highest in in the June 2022 quarter at -0.40. The PE Ratio was at its lowest in in the March 2020 quarter at -2966.29.

Vincerx Pharma, Inc. (VINC) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Vincerx Pharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vincerx Pharma, Inc. (VINC) Average PE Ratio

How has VINC PE Ratio performed in the past?

The current PE Ratio of Vincerx Pharma, Inc. (VINC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Vincerx Pharma, Inc. (VINC) PE Ratio vs. Peers

How is VINC’s PE Ratio compared to its peers?

Vincerx Pharma, Inc.’s PE Ratio is less than Spero Therapeutics, Inc. (17.30), greater than Bolt Biotherapeutics, Inc. (-0.30), greater than Coherus BioSciences, Inc. (-376.35), greater than Gracell Biotechnologies Inc. (-29.26), greater than Neoleukin Therapeutics, Inc. (-5.86), less than Applied Therapeutics, Inc. (-0.07), less than Lyra Therapeutics, Inc. (-0.12), greater than Shattuck Labs, Inc. (-0.76), greater than BioAtla, Inc. (-0.37), greater than Monopar Therapeutics Inc. (-0.59), greater than Senti Biosciences, Inc. (-0.27), greater than Processa Pharmaceuticals, Inc. (-0.25), greater than Fresh Tracks Therapeutics, Inc. (-3.09), greater than LAVA Therapeutics N.V. (-0.95), less than TRACON Pharmaceuticals, Inc. (0.02), greater than Rezolute, Inc. (-4.44), greater than XOMA Corporation (-10.60), greater than Sio Gene Therapies Inc. (-0.49), greater than Protara Therapeutics, Inc. (-2.75), less than Vaccinex, Inc. (-0.13), greater than Miromatrix Medical Inc. (-7.13), greater than Surrozen, Inc. (-0.89),

Build a custom stock screener for Vincerx Pharma, Inc. (VINC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vincerx Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vincerx Pharma, Inc. (VINC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vincerx Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.